Location: St. Helier, Jersey
CIK: 0001839209 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value: $620M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NTLA | INTELLIA THERAPEUTICS INC | 1,859,926 | $301M | 48.6% | $77.87 | 0.0% | COM | 45826J105 |
| — | ACCELERON PHARMA INC | 1,760,346 | $221M | 35.6% | $130.05 | — | COM | 00434H108 |
| FATE | FATE THERAPEUTICS INC | 335,918 | $29.15M | 4.7% | $72.37 | +11.4% | COM | 31189P102 |
| BBIO | BRIDGEBIO PHARMA INC | 336,817 | $20.53M | 3.3% | $59.97 | -4.8% | COM | 10806X102 |
| BEAM | BEAM THERAPEUTICS INC | 126,985 | $16.34M | 2.6% | $79.68 | 0.0% | COM | 07373V105 |
| — | VERVE THERAPEUTICS INC | 103,013 | $6.207M | 1.0% | $60.25 | — | COM | 92539P101 |
| — | INHIBRX INC | 225,480 | $6.205M | 1.0% | $27.97 | — | COM | 45720L107 |
| — | ESSA PHARMA INC | 208,524 | $5.958M | 1.0% | $28.57 | — | COM NEW | 29668H708 |
| KROS | KEROS THERAPEUTICS INC | 104,186 | $4.425M | 0.7% | $61.83 | -12.4% | COM | 492327101 |
| ACRS | ACLARIS THERAPEUTICS INC | 250,000 | $4.39M | 0.7% | $22.72 | 0.0% | COM | 00461U105 |
| RLAY | RELAY THERAPEUTICS INC | 119,775 | $4.383M | 0.7% | $43.40 | -24.1% | COM | 75943R102 |
| — | GENERATION BIO CO | 10,738 | $289K | 0.0% | $28.36 | — | COM | 37148K100 |